These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28964258)

  • 61. Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Trianty L; Kenangalem E; Noviyanti R; Campo B; Poespoprodjo JR; Möhrle JJ; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6117-24. PubMed ID: 26195523
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.
    Chung DI; Jeong S; Dinzouna-Boutamba SD; Yang HW; Yeo SG; Hong Y; Goo YK
    Malar J; 2015 Sep; 14():336. PubMed ID: 26337571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasmodium vivax trophozoites insensitive to chloroquine.
    Sharrock WW; Suwanarusk R; Lek-Uthai U; Edstein MD; Kosaisavee V; Travers T; Jaidee A; Sriprawat K; Price RN; Nosten F; Russell B
    Malar J; 2008 May; 7():94. PubMed ID: 18505560
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms.
    Wirjanata G; Handayuni I; Zaloumis SG; Chalfein F; Prayoga P; Kenangalem E; Poespoprodjo JR; Noviyanti R; Simpson JA; Price RN; Marfurt J
    Malar J; 2016 Mar; 15():137. PubMed ID: 26935745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.
    Loesbanluechai D; Kotanan N; de Cozar C; Kochakarn T; Ansbro MR; Chotivanich K; White NJ; Wilairat P; Lee MCS; Gamo FJ; Sanz LM; Chookajorn T; Kümpornsin K
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():16-22. PubMed ID: 30580023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.
    Kim YK; Kim C; Park I; Kim HY; Choi JY; Kim JM
    Am J Trop Med Hyg; 2011 Apr; 84(4):532-4. PubMed ID: 21460004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular detection of drug resistant malaria in Southern Thailand.
    Noisang C; Prosser C; Meyer W; Chemoh W; Ellis J; Sawangjaroen N; Lee R
    Malar J; 2019 Aug; 18(1):275. PubMed ID: 31416468
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
    Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular surveillance of the Plasmodium vivax multidrug resistance 1 gene in Peru between 2006 and 2015.
    Villena FE; Maguiña JL; Santolalla ML; Pozo E; Salas CJ; Ampuero JS; Lescano AG; Bishop DK; Valdivia HO
    Malar J; 2020 Dec; 19(1):450. PubMed ID: 33276776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of
    Tacoli C; Gai PP; Siegert K; Wedam J; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Gai P; Devi R; Mockenhaupt FP
    Am J Trop Med Hyg; 2019 Aug; 101(2):416-417. PubMed ID: 31218998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.
    Lu F; Gao Q; Chotivanich K; Xia H; Cao J; Udomsangpetch R; Cui L; Sattabongkot J
    Am J Trop Med Hyg; 2011 Aug; 85(2):197-201. PubMed ID: 21813834
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
    Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B
    Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Global assessment of genetic paradigms of Pvmdr1 mutations in chloroquine-resistant Plasmodium vivax isolates.
    Spotin A; Mahami-Oskouei M; Ahmadpour E; Parsaei M; Rostami A; Emami S; Gholipour S; Farmani M
    Trans R Soc Trop Med Hyg; 2020 May; 114(5):339-345. PubMed ID: 32100835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
    Parobek CM; Parr JB; Brazeau NF; Lon C; Chaorattanakawee S; Gosi P; Barnett EJ; Norris LD; Meshnick SR; Spring MD; Lanteri CA; Bailey JA; Saunders DL; Lin JT; Juliano JJ
    Genome Biol Evol; 2017 Jun; 9(6):1673-1686. PubMed ID: 28854635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular epidemiology of potential candidate markers for chloroquine resistance in imported Plasmodium vivax malaria cases in Iran.
    Pirahmadi S; Afzali S; Mehrizi AA; Raz A; Raeisi A
    Malar J; 2023 Apr; 22(1):118. PubMed ID: 37038137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.
    Heuchert A; Abduselam N; Zeynudin A; Eshetu T; Löscher T; Wieser A; Pritsch M; Berens-Riha N
    Malar J; 2015 May; 14():208. PubMed ID: 25986047
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
    Basco LK; Marquet F; Makler MM; Le Bras J
    Exp Parasitol; 1995 Mar; 80(2):260-71. PubMed ID: 7895836
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.